title: Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism.
abstract: BACKGROUND
  Vitamin D has several reported immunomodulatory properties including the reduced generation of pro-inflammatory CD4+ T helper 1 (Th1) cells and the increase in levels of the anti-inflammatory Th2 subset. Less clear has been the impact of vitamin D on the pro-inflammatory Th17 subset, and whether and how vitamin D may preferentially drive the polarization of one of the T helper subsets.
  
  
  METHODS
  Using human peripheral blood-derived mononuclear cells and mouse splenocytes and lymph node cells in culture, we examined whether and how vitamin D preferentially skews T cells towards the Th1, Th2 or Th17 subsets. Mice afflicted with the multiple sclerosis-like condition, experimental autoimmune encephalomyelitis (EAE), were examined in vivo for the relevance of the tissue culture-derived results.
  
  
  RESULTS
  We report that the biologically active form of vitamin D, 1,25-dihydroxyvitamin D3 {1,25(OH)2D3}, consistently generates human and murine Th2 cells in culture, frequently leaving unchanged the levels of Th1/Th17 cytokines. As a result, the ratio of Th2 to Th1 and Th17 is increased by 1,25(OH)2D3. The upregulation of Th2 to Th1 or Th17 subsets by 1,25(OH)2D3 is enabled by an increase of the GATA-3 transcription factor, which itself is promoted upstream by an elevation of the STAT6 transcription factor. In mice, the alleviation of EAE severity by 1,25(OH)2D3 is accompanied by elevation of levels of GATA-3 and STAT6. Significantly, the efficacy of 1,25(OH)2D3 in ameliorating EAE is completely lost in mice genetically deficient for STAT6, which was accompanied by the inability of 1,25(OH)2D3 to raise GATA-3 in STAT6 null lymphocytes.
  
  
  CONCLUSIONS
  These results of vitamin D promoting a Th2 shift through upstream GATA-3 and STAT6 transcription factors shed mechanistic understanding on the utility of vitamin D in MS.
authors: Hotchkiss Brain Institute and the Department of Clinical Neurosciences University of Calgary, Calgary, Alberta, Canada.
authors: Scott
authors: S
authors: Sloka
authors: Claudia
authors: C
authors: Silva
authors: Jianxiong
authors: J
authors: Wang
authors: V Wee
authors: VW
authors: Yong
references: J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):599-602
references: 7626516
references: PLoS One. 2009 Aug 13;4(8):e6635
references: 19675671
references: Arch Biochem Biophys. 2002 Dec 15;408(2):200-4
references: 12464272
references: J Neuroimmunol. 2001 Sep 3;119(1):16-29
references: 11525796
references: PLoS One. 2010 Sep 23;5(9):e12925
references: 20886077
references: BMJ. 2005 Jan 15;330(7483):120
references: 15585537
references: Can J Neurol Sci. 2011 Jan;38(1):98-105
references: 21156437
references: J Neurol. 2007 May;254(5):581-90
references: 17426912
references: J Neurosci Res. 2007 Aug 15;85(11):2480-90
references: 17600374
references: Lancet Neurol. 2010 Jun;9(6):599-612
references: 20494325
references: Lancet Neurol. 2004 Dec;3(12):709-18
references: 15556803
references: Immunity. 2000 Jan;12(1):27-37
references: 10661403
references: Brain. 2009 May;132(Pt 5):1146-60
references: 19321461
references: Mult Scler. 2009 Jan;15(1):9-15
references: 18701572
references: Clin Exp Immunol. 2010 Feb;159(2):109-19
references: 19912252
references: J Neuroimmunol. 2009 Aug 18;213(1-2):135-41
references: 19539379
references: J Neuroimmunol. 2005 Jan;158(1-2):213-21
references: 15589056
references: J Immunol. 2003 Jul 1;171(1):368-79
references: 12817020
references: Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861-4
references: 8755567
references: J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):189-95
references: 21047880
references: Med Hypotheses. 1986 Oct;21(2):193-200
references: 3537648
references: Eur J Immunol. 2000 Feb;30(2):498-508
references: 10671205
references: J Clin Invest. 1991 Mar;87(3):1103-7
references: 1705564
references: Nutr J. 2010 Dec 08;9:65
references: 21143872
references: J Immunol. 2001 Jun 15;166(12):7276-81
references: 11390477
references: Lancet Neurol. 2008 Mar;7(3):268-77
references: 18275928
references: Am J Pathol. 2009 Mar;174(3):898-909
references: 19218336
references: Eur J Clin Nutr. 2004 Aug;58(8):1095-109
references: 15054436
references: Nat Rev Immunol. 2008 Sep;8(9):685-98
references: 19172691
references: Ann Neurol. 2010 Aug;68(2):193-203
references: 20695012
references: J Pharmacol Exp Ther. 2008 Jan;324(1):23-33
references: 17911375
references: Nat Clin Pract Rheumatol. 2008 Aug;4(8):404-12
references: 18594491
references: J Exp Med. 2008 Jul 7;205(7):1517-22
references: 18591407
references: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6418-23
references: 20308557
references: J Immunol. 2005 Sep 15;175(6):4119-26
references: 16148162
references: J Immunol. 2006 Nov 1;177(9):6030-7
references: 17056528
references: Am J Hyg. 1960 Jul;72:88-99
references: 13791629
references: Annu Rev Nutr. 1988;8:375-99
references: 2849469
references: Semin Neurol. 2008 Feb;28(1):17-28
references: 18256984
references: Mult Scler. 2009 Aug;15(8):891-8
references: 19667017
references: Neurology. 2010 Jun 8;74(23):1852-9
references: 20427749
references: J Clin Endocrinol Metab. 1988 Aug;67(2):373-8
references: 2839537
references: Arch Biochem Biophys. 2000 May 1;377(1):135-8
references: 10775452
references: Ann Neurol. 2010 May;67(5):618-24
references: 20437559
references: Acta Neurol Scand. 2000 Sep;102(3):143-9
references: 10987373
references: Nat Immunol. 2007 Sep;8(9):942-9
references: 17676045
references: Acta Psychiatr Scand Suppl. 1960;35(147):132-47
references: 13681205
references: Eur J Immunol. 2011 Mar;41(3):822-32
references: 21287548
references: J Neuroimmunol. 1995 Sep;61(2):151-60
references: 7593550
references: J Immunol. 2009 Sep 15;183(6):3672-81
references: 19710457
references: J Clin Invest. 1998 Jan 1;101(1):252-62
references: 9421488